EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review

Ryota Fujikawa, Naoki Egami, Ryoji Mikubo, Kenta Kajiwara, Vlad Tocan, Yuhei Igata, Yuta Miyauchi, Kazuaki Yasuoka, Yasunari Sakai, Yuichi Mushimoto, Masayuki Ochiai, Hirosuke Inoue und 1 weitere

Neonatology · 2025

DOI: 10.1159/000549536 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neonatology, 2025. Verfasst von Ryota Fujikawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Gaucher Disease, Ambroxol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

High-dose ambroxol is an effective pharmacological chaperone therapy for the systemic and neurological symptoms of Gaucher disease (GD). However, no clinical evidence of perinatal-onset GD has been documented. Case Presentation: The patient had perinatal-onset neuronopathic GD (PnGD) and received high-dose ambroxol, beginning at 10 days of life after a newborn screening report. There was a transient hematological response after combined ambroxol and enzyme replacement therapy; however, laryngospasm, epileptic seizures, liver dysfunction, and heart failure progressed. The patient died 95 days after birth. Genetic testing revealed a homozygous L483R variant in GBA1. A literature review of 56 patients with nGD confirmed poor survival outcomes for patients with PnGD.

Conclusion

Ambroxol therapy may be insufficient to improve the prognosis of patients with PnGD, underscoring the limitations of early intervention in newborn-screened patients with GD. Therefore, pre-emptive therapeutic strategies are required to rescue and cure neonates with PnGD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gaucher DiseaseAmbroxolHumansInfant, NewbornFatal OutcomeFemaleMaleEnzyme Replacement TherapyGlucosylceramidase

Stichwörter der Autor:innen

AmbroxolGBA1LaryngospasmNeuronopathic Gaucher diseasePerinatal onsetPharmacological chaperone therapyp.L483R variant

Substanzen

AmbroxolGlucosylceramidase

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pediatrics, NHO Kokura Medical Center, Kitakyushu, Japan.
  • Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, egami.naoki.063@m.kyushu-u.ac.jp.
  • Department of Pediatrics, Fukuoka Red Cross Hospital, Fukuoka, Japan.
  • Department of Pediatrics, NHO Kyushu Medical Center, Fukuoka, Japan.
  • Research Center for Environmental and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan.

Zitieren

APA

Fujikawa, R., Egami, N., Mikubo, R., Kajiwara, K., Tocan, V., Igata, Y., Miyauchi, Y., Yasuoka, K., Sakai, Y., Mushimoto, Y., Ochiai, M., Inoue, H., & Ohga, S. (2025). Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review. Neonatology. https://doi.org/10.1159/000549536

Vancouver

Fujikawa R, Egami N, Mikubo R, Kajiwara K, Tocan V, Igata Y, et al. Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review. Neonatology. 2025. doi:10.1159/000549536

BibTeX
@article{Fujikawa2025,
  author = {Fujikawa, Ryota and Egami, Naoki and Mikubo, Ryoji and Kajiwara, Kenta and Tocan, Vlad and Igata, Yuhei and Miyauchi, Yuta and Yasuoka, Kazuaki and Sakai, Yasunari and Mushimoto, Yuichi and Ochiai, Masayuki and Inoue, Hirosuke and Ohga, Shouichi},
  title = {Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review},
  journal = {Neonatology},
  year = {2025},
  doi = {10.1159/000549536}
}
Kostenlos starten →